Skip to content
MARK EGLY

AATD and Cancer Prevention Research

Exploring how Alpha-1 Antitrypsin may relate to tumor biology

By Mark Egly Foundation

Research hypothesis. Connections between Alpha-1 Antitrypsin Deficiency (AATD), low circulating Alpha-1 Antitrypsin (AAT), and cancer described on this page reflect claims in Mark Egly's 2020 patent filing. They are not established medical fact and are not medical advice. Always talk with your doctor about your own health.

Why this topic matters

Cancer prevention is a major public health priority. Searches for lung, breast, and prostate cancer prevention attract millions of people each year. The Mark Egly Foundation's unique research angle asks whether restoring healthier AAT levels might influence inflammation and tissue damage pathways that appear in cancer biology.

This page is an education hub. It points you to disease pages in our catalog and to standard AATD resources. It does not claim that AAT treats or prevents cancer in clinical practice today.

What is established about AATD

Alpha-1 Antitrypsin Deficiency is a genetic condition that can cause lung disease (including emphysema and COPD) and liver disease. Testing and specialist care for severe AATD follow established clinical pathways. For a clear overview, start with What is Alpha-1 Antitrypsin Deficiency and symptoms.

What Mark Egly's patent explores

Mark Egly's patent discusses neutrophil elastase, thrombospondin-1 (TSP1), and circulating AAT in the context of tumor development and spread. The filing names multiple cancers, including breast cancer subtypes, among conditions that may relate to low AAT or AATD.

Those claims remain a research hypothesis. They require independent clinical validation before they can change the standard of care.

Breast cancer and Alpha-1

Breast cancer is one of the most searched cancer topics. Our enriched disease page explains the patent's discussion of breast tissue, smoking related damage to AAT, and TSP1:

Related catalog pages include metastatic, inflammatory, and triple negative breast cancer entries under Diseases (filter Cancer).

Other cancer pages in the catalog

Browse the full cancer category in the disease catalog. Examples include:

Each disease page offers layperson and professional audiences, with hypothesis labeling on every page.

What you can do

  1. Learn the established facts about AATD on our education pages.
  2. Discuss AAT testing with your clinician if you have unexplained lung or liver disease, or a family history of AATD.
  3. Read Mark's full patent overview for research context.
  4. Support research funding if you want to advance independent study of these questions.
  5. Clinicians can review AATD diagnosis and testing and join Uniting Doctors.